Alto Neuroscience, Inc. (ANRO)

NYSE: ANRO · Real-Time Price · USD

21.22

-0.32 (-1.49%)

At close: May 22, 2026, 4:00 PM EDT

21.87

+0.65 (3.04%)

After-hours: May 22, 2026, 7:00 PM EDT

Alto Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	263.76	176.48	168.23	82.55	48.34	25.71
Cash & Short-Term Investments	263.76	176.48	168.23	82.55	48.34	25.71
Cash Growth	64.08%	4.91%	103.79%	70.75%	88.07%	-
Accounts Receivable	-	-	-	-	-	1.5
Other Receivables	-	-	-	-	0.33	-
Total Trade Receivables	-	-	-	-	0.33	1.5
Other Current Assets	5.36	1.23	1.11	2.84	0.54	0.48
Total Current Assets	269.13	177.72	169.34	85.39	49.22	27.68
Net Property, Plant & Equipment	6.3	6.13	7.7	1.11	1.17	1.06
Other Long-Term Assets	0.84	0.84	0.5	0.13	0.46	0.05
Total Assets	276.26	184.69	177.54	86.63	50.85	28.79
Accounts Payable	3.37	1.88	1.58	1.07	1.61	0.6
Accrued Expenses	7.61	8.86	8.43	4.54	3.95	1.21
Current Portion of Long-Term Debt	2.14	0.59	-	-	-	-
Total Current Liabilities	13.12	11.33	10.01	5.61	5.56	1.81
Long-Term Debt	13.89	16.17	10.25	9.86	9.47	-
Long-Term Leases	3.56	3.82	4.52	-	-	-
Other Long-Term Liabilities	2.34	2.23	1.3	1.35	2	1.3
Total Long-Term Liabilities	19.78	22.22	16.07	11.21	11.47	1.3
Total Liabilities	32.89	33.55	26.08	16.82	17.03	3.11
Common Stock	0	0	0	-	-	-
Additional Paid-in Capital	471.22	352.75	289.95	5.37	2.3	0.49
Accumulated Other Comprehensive Income	0.01	0.02	-0.1	-0.08	-0.05	-0.02
Retained Earnings	-227.87	-201.63	-138.4	-76.97	-40.66	-12.95
Total Common Shareholders' Equity	243.37	151.14	151.46	-71.67	-38.41	-12.48
Minority Interest	-	-	-	141.48	72.24	38.16
Shareholders' Equity	243.37	151.14	151.46	69.81	33.83	25.69
Total Liabilities & Equity	276.26	184.69	177.54	86.63	50.85	28.79
Total Debt	19.58	20.58	14.77	9.86	9.47	0
Net Cash (Debt)	244.19	155.9	153.46	72.69	38.88	25.71
Net Cash Growth	56.63%	1.59%	111.12%	86.96%	51.25%	-
Net Cash Per Share	8.05	5.40	6.24	19.48	11.28	10.65
Book Value	243.37	151.14	151.46	-71.67	-38.41	-12.48
Book Value Per Share	8.03	5.24	6.16	-19.21	-11.15	-5.17
Tangible Book Value	243.37	151.14	151.46	-71.67	-38.41	-12.48
Tangible Book Value Per Share	8.03	5.24	6.16	-19.21	-11.15	-5.17

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q